The TP-PA test (Treponema pallidum particle agglutination test) is a blood test used to confirm whether someone has been infected with syphilis. It works by mixing a small sample of your blood with tiny gelatin particles coated in proteins from the syphilis-causing bacterium. If your blood contains antibodies against that bacterium, the particles clump together, producing a visible “reactive” result. The CDC considers it the preferred manual treponemal test for syphilis diagnosis.
How the TP-PA Test Works
Syphilis is caused by a spiral-shaped bacterium called Treponema pallidum. When your immune system encounters this bacterium, it produces specific antibodies to fight it. The TP-PA test detects those antibodies by exposing your blood serum to gelatin particles coated with pieces of the bacterium’s surface proteins. If the antibodies are present, they latch onto the particles and cause them to visibly clump together, a reaction called agglutination. A lab technician reads the result by looking at the pattern of particles in a small well plate: clumped particles mean reactive (positive), and evenly dispersed particles mean nonreactive (negative).
Because the test targets antibodies specific to the syphilis bacterium itself, it belongs to a category called treponemal tests. This distinguishes it from nontreponemal tests (like RPR or VDRL), which detect a different type of antibody your body produces in response to tissue damage caused by the infection rather than to the bacterium directly. That distinction matters for how each type of test is used and what the results mean.
Where It Fits in Syphilis Testing
No single blood test is enough to diagnose syphilis on its own. Labs use a combination of tests, and there are two main workflows.
In the traditional algorithm, your blood is first screened with a nontreponemal test like RPR or VDRL. These are fast and inexpensive, making them good for initial screening. If that screening test comes back reactive, the lab runs a treponemal test like the TP-PA to confirm the result is actually due to syphilis and not a false positive from another condition.
In the reverse algorithm, which many labs now use, the order flips. An automated treponemal test (usually an immunoassay run by a machine) screens the blood first. If that comes back positive, a nontreponemal test like RPR confirms whether the infection is currently active. When the two tests disagree, the CDC recommends using the TP-PA as a tiebreaker because it uses a different method and different antigens than the initial automated test, giving an independent second opinion.
This tiebreaker role is one of the TP-PA’s most important functions in modern lab practice. Discordant results (one test positive, the other negative) are common, and the TP-PA helps clarify whether a true infection is present.
Accuracy Across Syphilis Stages
The TP-PA’s accuracy varies depending on how far along the infection is. In primary syphilis, the earliest stage when a painless sore (chancre) first appears, sensitivity is around 88%, meaning it correctly identifies roughly 88 out of 100 infected people. It can miss some very early infections because the immune system hasn’t yet produced enough detectable antibodies.
Performance improves significantly in later stages. In secondary syphilis, when rashes and other symptoms develop, sensitivity reaches effectively 100%. In latent syphilis, the stage where symptoms disappear but the bacterium remains in the body, sensitivity is 97% or higher. Specificity, the test’s ability to correctly rule out people who don’t have syphilis, sits around 94-96% across stages. That high specificity is why the TP-PA is trusted as a confirmatory test: false positives are uncommon.
What a Positive Result Means
A reactive TP-PA result confirms that your body has produced antibodies against the syphilis bacterium at some point. This is a critical detail: the TP-PA cannot distinguish between a current active infection and one that was successfully treated years ago. Once you’ve had syphilis, treponemal antibodies typically remain in your blood for life, even after treatment. So a positive TP-PA in someone who was previously treated does not necessarily mean they are infected again.
That’s why treponemal tests like the TP-PA are always paired with nontreponemal tests. The nontreponemal test measures a different kind of antibody that rises during active infection and drops after successful treatment. If your TP-PA is reactive but your RPR is nonreactive, the most likely explanation is a past infection that has already been treated or resolved. If both are reactive, the infection is more likely to be current or recent, and the RPR titer (a measure of how concentrated those antibodies are) helps gauge how active it is.
What a Negative Result Means
A nonreactive TP-PA result generally means you have not been infected with syphilis. However, there is one important caveat: very early infection. During the first few weeks after exposure, your body may not have produced enough antibodies for any blood test to detect. This window period means a negative result doesn’t completely rule out a brand-new infection if you were recently exposed. If there’s a strong clinical suspicion, retesting after a few weeks is standard practice.
Why the TP-PA Is Preferred Over Older Tests
The TP-PA replaced an older test called the FTA-ABS (fluorescent treponemal antibody absorption test) as the go-to manual confirmatory test. The FTA-ABS requires a fluorescence microscope and a trained technician to interpret results, which introduces more room for subjective judgment. The TP-PA is simpler to perform and read, doesn’t require specialized microscopy equipment, and produces results that are easier to interpret consistently across different labs.
Another older test, the TPHA (Treponema pallidum hemagglutination assay), uses red blood cells instead of gelatin particles. The TP-PA works on the same principle but with synthetic gelatin particles, which gives more consistent results and avoids issues related to sourcing and standardizing animal red blood cells. In the United States, the TP-PA is the standard; the TPHA is more commonly used in other countries but functions very similarly.
Causes of False Results
False positives on the TP-PA are uncommon given its high specificity, but they can occur. Other spirochetal infections, caused by bacteria structurally similar to the syphilis bacterium, can occasionally trigger a reactive result. Lyme disease is the most well-known example. Certain autoimmune conditions may also rarely cause false-positive treponemal tests.
False negatives are more of a concern in very early primary syphilis, before the immune response has fully developed. In secondary and latent stages, the test is highly reliable. In people with severely compromised immune systems, antibody production can be blunted enough to affect test performance, though this is unusual.
Nontreponemal tests like RPR have a broader list of conditions that can cause false positives, including pregnancy, lupus, and certain viral infections. This is precisely why combining both test types gives a much clearer picture than either one alone.